Risperdal Gynecomastia Defense Verdict Reversed On Appeal For ‘Expert’ Testimony

(November 14, 2017, 12:25 PM EST) -- PHILADELPHIA — A Pennsylvania state appeals court panel on Nov. 13 reversed a Risperdal gynecomastia defense verdict, finding that the trial court erred in not treating physician assistant’s testimony as that of a causation expert (W.C. v. Janssen Pharmaceuticals, Inc., et al., No. 2451 EDA 2015, Pa. Super., 2017 Pa. Super. LEXIS 909).

(Opinion available.  Document #28-171116-010Z.)

A plaintiff identified only as W.C., was 6 when he was prescribed the atypical antipsychotic drug Risperdal in 2001 to treat attention deficit/hyperactivity disorder and oppositional defiant disorder.  Risperdal...
To view the full article, register now.